UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000046203
Receipt No. R000052488
Scientific Title Continuous monitoring of analgesia and sedation using wearable device with motion sensors in a pediatric intensive care unit
Date of disclosure of the study information 2021/12/01
Last modified on 2021/11/26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Continuous monitoring of analgesia and sedation using wearable device with motion sensors in a pediatric intensive care unit
Acronym Continuous monitoring of analgesia and sedation using wearable device with motion sensors in a pediatric intensive care unit
Scientific Title Continuous monitoring of analgesia and sedation using wearable device with motion sensors in a pediatric intensive care unit
Scientific Title:Acronym Continuous monitoring of analgesia and sedation using wearable device with motion sensors in a pediatric intensive care unit
Region
Japan

Condition
Condition Childern in a pediatric intensive care unit
Classification by specialty
Intensive care medicine Child
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To confirm the usefulness of continuous monitoring of analgesia and sedation using wearable device with motion sensors.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes (1)Correlation between body motion data such as frequency, duration, and intensity of body movements assessed by accelerometers and the SBS/RASS analgesic sedation scale assessed by observers.
Key secondary outcomes (2) The incidence of discomfort, restlessness, or inability to continue wearing the wearable device, and the adverse events such as dermatitis.
(3) Association between the patient's restlessness, dangerous behaviors, and asynchronization with the mechanical ventilation observed by medical staff and inappropriate sedation state based on body motion data.
(4) Correlation between analgesic sedation evaluation using SBS/RASS analgesic sedation scale and body motion data with image information such as eye opening and crying.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Device,equipment
Interventions/Control_1 Wearable device
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit
15 years-old >=
Gender Male and Female
Key inclusion criteria Children in pediatric intensive care unit
Key exclusion criteria Exclude patients on muscle relaxants, with tetraplegia, with restrainer, with severe contractures, and with difficulty in wearing a wearable device, who have difficulty in assessing body movements. Patients with severe mental retardation who are difficult to assess for analgesia and sedation by SBS/RASS should also be excluded.
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Takeshi
Middle name
Last name Hatachi
Organization Osaka Women's and Children's Hospital
Division name Department of Intensive Care Medicine
Zip code 594-1101
Address Murodo-cho 840, Izumi-City, Osaka, 594-1101 Japan
TEL 0725-56-1220
Email hatachi@mch.pref.osaka.jp

Public contact
Name of contact person
1st name Takeshi
Middle name
Last name Hatachi
Organization Osaka Women's and Children's Hospital
Division name Department of Intensive Care Medicine
Zip code 594-1101
Address Murodo-cho 840, Izumi-City, Osaka, 594-1101 Japan
TEL 0725-56-1220
Homepage URL
Email hatachi@mch.pref.osaka.jp

Sponsor
Institute Osaka Women's and Children's Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Osaka Women's and Children's Hospital
Address Murodo-cho 840, Izumi-City, Osaka, 594-1101 Japan
Tel 0725-56-1220
Email hatachi@mch.pref.osaka.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 大阪母子医療センター

Other administrative information
Date of disclosure of the study information
2021 Year 12 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2021 Year 12 Month 01 Day
Date of IRB
2021 Year 12 Month 01 Day
Anticipated trial start date
2021 Year 12 Month 01 Day
Last follow-up date
2026 Year 11 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 11 Month 26 Day
Last modified on
2021 Year 11 Month 26 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052488

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.